Astrocytic Endocannabinoids Mediate Hippocampal Transient Heterosynaptic Depression

Area of Science:

• Neuroscience
• Cellular Neuroscience
• Synaptic Plasticity

Background:

• Astrocytes dynamically regulate synaptic transmission.
• Transient Heterosynaptic Depression (tHSD) is a rapid form of synaptic modulation (milliseconds to seconds).
• The precise mechanisms of astrocytic control over tHSD remain unclear, with traditional gliotransmitter pathways being questioned.

Purpose of the Study:

• To elucidate the astrocytic mechanisms underlying Transient Heterosynaptic Depression (tHSD).
• To investigate the roles of hemichannels, vesicles, and novel pathways in astrocytic modulation of tHSD.
• To identify the specific signaling molecules involved in astrocytic tHSD.

Main Methods:

• Utilized genetic manipulation (connexin 43/30 and IP3R2 knockout mice, dominant-negative SNARE mice).
• Employed pharmacological agents including a Krebs cycle inhibitor (fluoroacetate), group II mGluR agonist, CB1R antagonist, and 2-AG degradation inhibitor.
• Performed experiments on hippocampal slices to assess synaptic activity.

Main Results:

• Confirmed astrocytes are essential for tHSD.
• Demonstrated that vesicular gliotransmitter release and adenosine A1 receptor activation are not required for tHSD.
• Showed that group II metabotropic glutamate receptors (mGluRs) are involved.
• Provided evidence for the involvement of astrocyte-derived endocannabinoids, specifically via cannabinoid receptor 1 (CB1R).

Conclusions:

• Astrocytes modulate tHSD through a novel pathway involving group II mGluR-mediated endocannabinoid signaling.
• This pathway leads to the transient suppression of presynaptic neurotransmitter release.
• Findings exclude traditional gliotransmitter release mechanisms (hemichannels, vesicles) and adenosine signaling in tHSD.